Chad Patterson serves as the Chief Commercial Officer at iRhythm Technologies, Inc., a leading digital health company focused on the advancement of cardiac care through innovative technology. In his role, Patterson is responsible for overseeing the company's commercial strategy, sales, and marketing efforts, driving the adoption of iRhythm's flagship product, the Zio XT, a long-term continuous monitoring solution for detecting cardiac arrhythmias. His leadership has been instrumental in expanding the company's reach and solidifying its position as a key player in the cardiac monitoring industry. Patterson brings a wealth of experience to iRhythm, having spent over two decades in the healthcare and medical device sectors. Prior to joining iRhythm, he held various senior leadership positions at notable companies such as Medtronic and Boston Scientific, where he successfully led teams in the development and commercialization of innovative medical technologies. His strategic vision and ability to navigate complex market landscapes have been key factors in his success. Patterson's expertise in sales, marketing, and business development has enabled him to drive growth and foster strong relationships with healthcare providers and patients alike. Under Patterson's guidance, iRhythm has experienced significant growth and recognition within the industry. His commitment to improving patient outcomes through advanced technology has been a driving force behind the company's mission. Patterson's leadership style emphasizes collaboration, innovation, and a patient-centric approach, which has helped iRhythm maintain its competitive edge and continue to expand its offerings. As Chief Commercial Officer, Chad Patterson remains dedicated to advancing iRhythm's goal of transforming cardiac care and improving the lives of patients worldwide.